SAT1 and obesity disorder: In a mouse model of diet-induced obesity, chemically activating Sat1 via the synthetic agent triethylenetetramine dihydrochloride stimulated autophagy, reduced weight, and improved both fatty liver and glucose intolerance (Castoldi et al., 2020).